Schedule optimization of hydroxyurea and 1-beta-D-arabinofuranosylcytosine in sarcoma 180 in vitro.
D000818:Animals; D002470:Cell Survival / Q000187:drug effects; D002999:Clone Cells; D003561:Cytarabine / Q000008:administration & dosage / Q000627:therapeutic use*; D004261:DNA Replication / Q000187:drug effects; D004305:Dose-Response Relationship, Drug; D004334:Drug Administration Schedule; D005434:Flow Cytometry; D006918:Hydroxyurea / Q000008:administration & dosage / Q000627:therapeutic use*; D007700:Kinetics; D051379:Mice; D012510:Sarcoma 180 / Q000188:drug therapy* / Q000503:physiopathology
D003561:Cytarabine; D006918:Hydroxyurea